The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neuromodulation Devices and Implantable Infusion Pumps Market Research Report 2025
Synopsis
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
The global Neuromodulation Devices and Implantable Infusion Pumps market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.
This report aims to provide a comprehensive presentation of the global market for Neuromodulation Devices and Implantable Infusion Pumps, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuromodulation Devices and Implantable Infusion Pumps.
Report Scope
The Neuromodulation Devices and Implantable Infusion Pumps market size, estimations, and forecasts are provided in terms of sales volume (Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuromodulation Devices and Implantable Infusion Pumps market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuromodulation Devices and Implantable Infusion Pumps manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Segment by Type
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segment by Application
Parkinson's Disease
Epilepsy
Pain
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neuromodulation Devices and Implantable Infusion Pumps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neuromodulation Devices and Implantable Infusion Pumps in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
The global Neuromodulation Devices and Implantable Infusion Pumps market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.
This report aims to provide a comprehensive presentation of the global market for Neuromodulation Devices and Implantable Infusion Pumps, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuromodulation Devices and Implantable Infusion Pumps.
Report Scope
The Neuromodulation Devices and Implantable Infusion Pumps market size, estimations, and forecasts are provided in terms of sales volume (Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuromodulation Devices and Implantable Infusion Pumps market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuromodulation Devices and Implantable Infusion Pumps manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Segment by Type
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segment by Application
Parkinson's Disease
Epilepsy
Pain
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neuromodulation Devices and Implantable Infusion Pumps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neuromodulation Devices and Implantable Infusion Pumps in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Neuromodulation Devices and Implantable Infusion Pumps Market Overview
1.1 Product Overview and Scope of Neuromodulation Devices and Implantable Infusion Pumps
1.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Value Comparison by Type (2024-2030)
1.2.2 Spinal Cord Stimulation
1.2.3 Deep Brain Stimulation
1.2.4 Sacral Nerve Stimulation
1.2.5 Vagal Nerve Stimulation
1.2.6 Gastric Stimulation
1.2.7 Transcranial Magnetic Stimulation
1.2.8 Transcutaneous Electrical Stimulation
1.2.9 Other
1.3 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Value by Application: (2024-2030)
1.3.2 Parkinson's Disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Other
1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Estimates and Forecasts
1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue 2019-2030
1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales 2019-2030
1.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neuromodulation Devices and Implantable Infusion Pumps Market Competition by Manufacturers
2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturers (2019-2024)
2.4 Global Neuromodulation Devices and Implantable Infusion Pumps Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Product Type & Application
2.7 Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Situation and Trends
2.7.1 Neuromodulation Devices and Implantable Infusion Pumps Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue
2.7.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neuromodulation Devices and Implantable Infusion Pumps Retrospective Market Scenario by Region
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2019-2030
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2019-2024
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2025-2030
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2019-2030
3.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2019-2024
3.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2025-2030
3.4 North America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.4.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2030)
3.4.3 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.5.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2030)
3.5.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.6.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2030)
3.6.3 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.7.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2030)
3.7.3 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.8.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2030)
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2024)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2025-2030)
4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2019-2030)
4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2019-2030)
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2019-2024)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2025-2030)
4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2019-2030)
4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2030)
5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2024)
5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2025-2030)
5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2019-2030)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2019-2030)
5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2019-2024)
5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2025-2030)
5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2019-2030)
5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 St. Jude Medical
6.3.1 St. Jude Medical Corporation Information
6.3.2 St. Jude Medical Description and Business Overview
6.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)
6.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.3.5 St. Jude Medical Recent Developments/Updates
6.4 Synapse Biomedical
6.4.1 Synapse Biomedical Corporation Information
6.4.2 Synapse Biomedical Description and Business Overview
6.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.4.5 Synapse Biomedical Recent Developments/Updates
6.5 Nevro Corporation
6.5.1 Nevro Corporation Corporation Information
6.5.2 Nevro Corporation Description and Business Overview
6.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.5.5 Nevro Corporation Recent Developments/Updates
6.6 Neuropace
6.6.1 Neuropace Corporation Information
6.6.2 Neuropace Description and Business Overview
6.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.6.5 Neuropace Recent Developments/Updates
6.7 Cyberonics
6.6.1 Cyberonics Corporation Information
6.6.2 Cyberonics Description and Business Overview
6.6.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.7.5 Cyberonics Recent Developments/Updates
6.8 Autonomic Technologies
6.8.1 Autonomic Technologies Corporation Information
6.8.2 Autonomic Technologies Description and Business Overview
6.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.8.5 Autonomic Technologies Recent Developments/Updates
6.9 Avery Biomedical
6.9.1 Avery Biomedical Corporation Information
6.9.2 Avery Biomedical Description and Business Overview
6.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.9.5 Avery Biomedical Recent Developments/Updates
6.10 Greatbatch Medical
6.10.1 Greatbatch Medical Corporation Information
6.10.2 Greatbatch Medical Description and Business Overview
6.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.10.5 Greatbatch Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Chain Analysis
7.2 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process
7.4 Neuromodulation Devices and Implantable Infusion Pumps Sales and Marketing
7.4.1 Neuromodulation Devices and Implantable Infusion Pumps Sales Channels
7.4.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
7.5 Neuromodulation Devices and Implantable Infusion Pumps Customers
8 Neuromodulation Devices and Implantable Infusion Pumps Market Dynamics
8.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
8.2 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
8.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
8.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
